• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单克隆丙种球蛋白病中的自然杀伤细胞活性:与疾病活动的关系。

Natural killer cell activity in monoclonal gammopathies: relation to disease activity.

作者信息

Osterborg A, Nilsson B, Björkholm M, Holm G, Mellstedt H

机构信息

Department of Oncology (Radiumhemmet), Karolinska Hospital, Stockholm, Sweden.

出版信息

Eur J Haematol. 1990 Sep;45(3):153-7. doi: 10.1111/j.1600-0609.1990.tb00443.x.

DOI:10.1111/j.1600-0609.1990.tb00443.x
PMID:1699786
Abstract

Natural killer (NK) activity and NK-related cell surface markers (CD16, CD56, CD57) of peripheral blood lymphocytes were studied in patients with multiple myeloma and MGUS (monoclonal gammopathy of undetermined significance). A strong correlation (p less than 0.0001) was found between the numbers of cells positive for the different NK cell surface markers. The proportion of CD16+ cells correlated highly to the lytic capability (lytic units/10(6) cells) of K562 cells (p less than 0.0001). High NK activity and high numbers of cells with NK-related cell surface markers were found in patients with a low tumor burden compared to controls, whereas low values were seen in patients with an advanced disease. The results indicate that NK cells might be involved in the disease process in monoclonal gammopathies, perhaps by exerting a regulatory function on the proliferating B-cell clone.

摘要

对多发性骨髓瘤和意义未明的单克隆丙种球蛋白病(MGUS)患者外周血淋巴细胞的自然杀伤(NK)活性及NK相关细胞表面标志物(CD16、CD56、CD57)进行了研究。发现不同NK细胞表面标志物阳性细胞数量之间存在强相关性(p<0.0001)。CD16+细胞比例与K562细胞的裂解能力(裂解单位/10⁶细胞)高度相关(p<0.0001)。与对照组相比,肿瘤负荷低的患者NK活性高,且具有NK相关细胞表面标志物的细胞数量多,而病情进展的患者NK活性和细胞数量值较低。结果表明,NK细胞可能参与了单克隆丙种球蛋白病的疾病过程,可能是通过对增殖的B细胞克隆发挥调节作用。

相似文献

1
Natural killer cell activity in monoclonal gammopathies: relation to disease activity.单克隆丙种球蛋白病中的自然杀伤细胞活性:与疾病活动的关系。
Eur J Haematol. 1990 Sep;45(3):153-7. doi: 10.1111/j.1600-0609.1990.tb00443.x.
2
Natural killer cell frequency and function in patients with monoclonal gammopathies.单克隆丙种球蛋白病患者自然杀伤细胞的频率和功能
J Clin Lab Immunol. 1992;37(3):99-109.
3
Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu-19).
Blood. 1990 Jul 15;76(2):377-82.
4
Accumulation of CD16-CD56+ natural killer cells with high affinity interleukin 2 receptors in human early pregnancy decidua.具有高亲和力白细胞介素2受体的CD16-CD56+自然杀伤细胞在人早孕蜕膜中的积聚。
Int Immunol. 1991 Aug;3(8):743-50. doi: 10.1093/intimm/3.8.743.
5
Analysis of natural killer-associated antigens in peripheral blood and bone marrow of multiple myeloma patients and prognostic implications.多发性骨髓瘤患者外周血和骨髓中自然杀伤相关抗原的分析及其预后意义。
Br J Haematol. 1996 Apr;93(1):81-8. doi: 10.1046/j.1365-2141.1996.4651006.x.
6
Monocyte-induced down-modulation of CD16 and CD56 antigens on human natural killer cells and its regulation by histamine H2-receptors.
Cell Immunol. 1991 Nov;138(1):44-54. doi: 10.1016/0008-8749(91)90131-t.
7
Redistribution of natural killer (NK) cell frequency and NK cytotoxic activity in primary IgA nephropathy.原发性IgA肾病中自然杀伤(NK)细胞频率及NK细胞毒性活性的重新分布
Cytobios. 1992;69(276):27-34.
8
The CD56 adhesion molecule is the major determinant for detecting non-major histocompatibility complex-restricted cytotoxic mononuclear cells from the intestinal lamina propria.CD56黏附分子是检测来自肠道固有层的非主要组织相容性复合体限制的细胞毒性单核细胞的主要决定因素。
Eur J Immunol. 1992 Jan;22(1):23-9. doi: 10.1002/eji.1830220105.
9
In vitro responsiveness to interleukins and theophylline of CD16+, CD56- natural killer cells in a patient with chronic granular lymphocyte disorder.慢性颗粒淋巴细胞疾病患者中CD16 +、CD56 - 自然杀伤细胞对白介素和茶碱的体外反应性
Leukemia. 1992 May;6(5):470-6.
10
Patterns of CD16 and CD56 expression in persistent expansions of CD3+NKa+ lymphocytes are predictive for clonal T-cell receptor gene rearrangements. The Yorkshire Leukaemia Group.CD3⁺NKa⁺淋巴细胞持续扩增中CD16和CD56的表达模式可预测克隆性T细胞受体基因重排。约克郡白血病研究小组。
Br J Haematol. 1991 Jul;78(3):368-77. doi: 10.1111/j.1365-2141.1991.tb04450.x.

引用本文的文献

1
Natural killer cell biology and therapy in multiple myeloma: challenges and opportunities.多发性骨髓瘤中的自然杀伤细胞生物学与治疗:挑战与机遇
Exp Hematol Oncol. 2024 Nov 13;13(1):114. doi: 10.1186/s40164-024-00578-4.
2
Deep Immune Profiling of Multiple Myeloma at Diagnosis and under Lenalidomide Maintenance Therapy.多发性骨髓瘤诊断时及来那度胺维持治疗下的深度免疫剖析
Cancers (Basel). 2023 May 4;15(9):2604. doi: 10.3390/cancers15092604.
3
Monoclonal Gammopathies and the Bone Marrow Microenvironment: From Bench to Bedside and Then Back Again.
单克隆丙种球蛋白病与骨髓微环境:从 bench 到 bedside 再回归 bench
Hematol Rep. 2023 Jan 9;15(1):23-49. doi: 10.3390/hematolrep15010004.
4
CRISPR-Cas9 based gene editing of the immune checkpoint NKG2A enhances NK cell mediated cytotoxicity against multiple myeloma.基于 CRISPR-Cas9 的免疫检查点 NKG2A 基因编辑增强 NK 细胞对多发性骨髓瘤的细胞毒性。
Oncoimmunology. 2022 May 31;11(1):2081415. doi: 10.1080/2162402X.2022.2081415. eCollection 2022.
5
Natural Killer Cells in the Malignant Niche of Multiple Myeloma.自然杀伤细胞在多发性骨髓瘤的恶性微环境中。
Front Immunol. 2022 Jan 11;12:816499. doi: 10.3389/fimmu.2021.816499. eCollection 2021.
6
Predictive Role of Immune Profiling for Survival of Multiple Myeloma Patients.免疫特征分析对多发性骨髓瘤患者生存的预测作用。
Front Immunol. 2021 Jul 5;12:663748. doi: 10.3389/fimmu.2021.663748. eCollection 2021.
7
Autologous Stem Cell Transplantation for Myeloma: Cytoreduction or an Immunotherapy?自体干细胞移植治疗骨髓瘤:细胞减灭还是免疫疗法?
Front Immunol. 2021 Mar 12;12:651288. doi: 10.3389/fimmu.2021.651288. eCollection 2021.
8
Co-evolution of Immune Response in Multiple Myeloma: Implications for Immune Prevention.多发性骨髓瘤中免疫反应的共同进化:对免疫预防的启示。
Front Immunol. 2021 Feb 26;12:632564. doi: 10.3389/fimmu.2021.632564. eCollection 2021.
9
Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma.单细胞 RNA 测序揭示多发性骨髓瘤前体阶段免疫微环境受损。
Nat Cancer. 2020 May;1(5):493-506. doi: 10.1038/s43018-020-0053-3. Epub 2020 Apr 27.
10
Haploidentical transplantation in patients with multiple myeloma making use of natural killer cell alloreactive donors.利用自然杀伤细胞同种反应性供体进行多发性骨髓瘤患者的单倍体相合移植。
Ann Hematol. 2021 Jan;100(1):181-187. doi: 10.1007/s00277-020-04303-z. Epub 2020 Oct 28.